If you have managed or currently manage a clinical study budget you have likely heard the following questions or statements from your finance teams or senior management: Why are investigator fees so much higher than originally planned? What do you mean we have another unplanned CRO change order? Many different drivers contribute to actual clinical study budgets being much higher or lower than originally planned – some may be inevitable and some within our control. On this week’s video, we discuss the most expensive cost categories in a clinical study budget and the top tips that will have the biggest impact in our clinical study budgets.
Let us know your thoughts and any topics you would like discussed in upcoming videos and interviews related to clinical business. Also, if you think of anyone else who may be benefited by this information, go ahead and share!